Novavax reports FDA placed clinical hold on IND for COVID-flu combo vaccine
Novavax announced that the U.S. Food and Drug Administration has placed a clinical hold on Novavax’s Investigational New Drug, or IND, application for its COVID-19-Influenza Combination, or CIC, and stand-alone influenza vaccine candidates.
The ideal time to get the flu vaccine is by the end of October, the FDA said in a news release. “Flu viruses typically spread ...
The project — in collaboration with Erasmus University in the Netherlands — is supported by a recent $7 million grant from ...
FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for ...
An infant, and a 90+ year-old adult, were the first Connecticut residents to die from the flu in the 2024-25 season.
The Respiratory Surveillance Service has begun operating in Hungary as a first step in preparing for the flu season.
Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include ...
The U.S. Food and Drug Administration (FDA) has updated the label for FLUBLOK (Influenza Vaccine) to include data from a new safety study involving pregnant individuals 18 years and older, in time to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback